Drug intelligence / Profile preview

Nevamast Gel

Development stage
Unknown
Lead developer
Epitech
Modality
Small Molecules
Administration
Topical
01

Overview

Nevamast Gel is a sterile topical medical device developed by Epitech Group SpA for the treatment of skin lesions healing by secondary intention. It is an ALIAmide-based isosmotic hydrophilic gel containing adelmidrol and trans-traumatic acid. Adelmidrol promotes the physiological endogenous increase of palmitoylethanolamide (PEA), which modulates mast cells and other non-neuronal immune cells to maintain neuro-vascular balance and support tissue repair. Trans-traumatic acid facilitates keratinocyte convergence and re-epithelialization while providing a barrier against microbial colonization. The product is indicated for varicose ulcers of the lower limbs, pressure sores, and skin lesions associated with microcirculatory disorders or podology conditions.

Brand names
Nevamast Gel
Other names
Nevamast
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)PPARA (Peroxisome proliferator-activated receptor alpha)GPR55 (G protein-coupled receptor 55)

Beyond the preview

Go deeper on Nevamast Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nevamast Gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call